Incidence and predictors of nonresponse to intranasal midazolam in children undergoing laceration repair
- 3 February 2025
- journal article
- Published by Wiley in Academic Emergency Medicine
- Vol. 32 (7) , 768-775
Abstract
Background/objective: Pediatric laceration repairs are common in the emergency department (ED) and often associated with significant procedural anxiety. Despite the increased use of intranasal midazolam (INM) prior to pediatric ED procedures, there is limited, real‐world data on the effects of INM on anxiety. This study aimed to describe the proportion of children who were nonresponsive to INM (i.e., exhibited extreme anxiety) and identify factors associated with INM nonresponse.Methods: This cross‐sectional study included a sample of 102 children (ages 2–10 years) who received 0.2 mg/kg INM prior to laceration repair in the ED. Procedural anxiety was assessed using the modified Yale Preoperative Anxiety Scale (mYPAS). Children exhibiting extreme procedural anxiety (mYPAS score ≥72.91) when procedure started were labeled as INM nonresponders. Bivariate and multivariable logistic regression analyses explored associations between child age, temperament, laceration location, time from INM administration, and likelihood of INM nonresponse.Results: In this sample, 45.1% of the children were classified as INM nonresponders, exhibiting extreme procedural anxiety. Bivariate analyses indicated that nonresponders were younger, had lower sociability temperament, longer delay between INM administration and the procedure, and were more likely to have extremity lacerations. In the logistic regression, younger age (odds ratio [OR] 0.79, p = 0.034), lower sociability temperament (OR 0.28, p = 0.002), and extremity lacerations (OR 8.04, p = 0.009) were significantly associated with likelihood of INM nonresponse.Conclusions: Nearly half of the children in our sample exhibited extreme procedural anxiety despite receiving INM. The high incidence of nonresponse to INM has important clinical practice implications and suggests that 0.2 mg/kg INM alone may not be sufficient to manage all pediatric procedural anxiety in the ED. Findings highlight a need for further research examining multimodal strategies to manage procedural anxiety in the pediatric ED, particularly for younger children with low sociability temperament or extremity lacerations.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K23HD105042)
This publication has 37 references indexed in Scilit:
- Intranasal midazolam for procedural distress in children in the emergency department: a systematic review and meta-analysisCanadian Journal of Emergency Medicine, 2024
- Association of Temperament With Preoperative Anxiety in Pediatric Patients Undergoing SurgeryJAMA Network Open, 2019
- Adverse events and satisfaction with use of intranasal midazolam for emergency department procedures in childrenThe American Journal of Emergency Medicine, 2019
- Assessment of Acute Pain in ChildrenClinical Pediatric Emergency Medicine, 2017
- Altered stress system reactivity after pediatric injury: Relation with post-traumatic stress symptomsPsychoneuroendocrinology, 2017
- Optimal Volume of Administration of Intranasal Midazolam in Children: A Randomized Clinical TrialAnnals of Emergency Medicine, 2017
- A Randomized Clinical Trial Comparing Oral, Aerosolized Intranasal, and Aerosolized Buccal MidazolamAnnals of Emergency Medicine, 2011
- National trends in ED lacerations between 1992 and 2002The American Journal of Emergency Medicine, 2006
- Preoperative Anxiety in ChildrenArchives of Pediatrics & Adolescent Medicine, 1996
- A Randomized, Controlled Trial of Oral Midazolam and Buffered Lidocaine for Suturing Lacerations in Children (the SLIC Trial)Annals of Emergency Medicine, 1995